Uniplan Investment Counsel’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-97,375
Closed -$982K 127
2019
Q2
$982K Sell
97,375
-25,964
-21% -$295K 0.06% 119
2019
Q1
$1.73M Sell
123,339
-22,338
-15% -$384K 0.11% 111
2018
Q4
$2.31M Sell
145,677
-4,494
-3% -$77.5K 0.16% 95
2018
Q3
$2.82M Sell
150,171
-17,761
-11% -$354K 0.16% 96
2018
Q2
$3.23M Sell
167,932
-25,132
-13% -$510K 0.16% 97
2018
Q1
$4.12M Sell
193,064
-3,818
-2% -$79.3K 0.19% 95
2017
Q4
$4.05M Buy
196,882
+5,060
+3% +$93.9K 0.17% 109
2017
Q3
$3.54M Sell
191,822
-61,829
-24% -$1.36M 0.15% 108
2017
Q2
$6.33M Sell
253,651
-508
-0.2% -$10.7K 0.28% 77
2017
Q1
$5.09M Buy
254,159
+5,429
+2% +$119K 0.23% 86
2016
Q4
$6.14M Sell
248,730
-205,691
-45% -$4.61M 0.28% 82
2016
Q3
$9.01M Buy
454,421
+8,508
+2% +$158K 0.41% 59
2016
Q2
$6.13M Buy
445,913
+25,189
+6% +$350K 0.28% 67
2016
Q1
$5.79M Buy
420,724
+1,443
+0.3% +$16.5K 0.28% 69
2015
Q4
$4.25M Buy
419,281
+7,835
+2% +$85.3K 0.21% 93
2015
Q3
$4.13M Buy
411,446
+46,615
+13% +$543K 0.2% 90
2015
Q2
$5.41M Buy
+364,831
New +$5.68M 0.25% 83

Other funds holding PMD

Uniplan Investment Counsel's PMD Position: Q3 2019 in Review

Uniplan Investment Counsel sold out of Psychemedics Corporation (PMD) in Q3 2019, closing a stake of 97,375 shares — an estimated $982K sold.

Uniplan Investment Counsel first reported a position in PMD in Q2 2015 and held it in 17 quarters. The position peaked at $9.01M in Q3 2016. 45 funds tracked by Wall St. Rank hold PMD as of Q3 2019.

  • Uniplan Investment Counsel reported no remaining Psychemedics Corporation position as of Q3 2019 after selling out during the quarter.
  • Uniplan Investment Counsel sold 97,375 Psychemedics Corporation shares in Q3 2019, an estimated $982K.
  • Uniplan Investment Counsel first reported a position in Psychemedics Corporation in Q2 2015 and held it in 17 quarters.
  • Uniplan Investment Counsel's Psychemedics Corporation position peaked at $9.01M in Q3 2016.
  • 45 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q3 2019.

Based on Uniplan Investment Counsel's 13F filing for Q3 2019, filed 14 Nov 2019.